173 related articles for article (PubMed ID: 33677882)
1. [Clinicopathological features of notochordal tumors: a study of 48 cases].
Huang J; Yang TT; Jiang ZM; Zhang HZ
Zhonghua Bing Li Xue Za Zhi; 2021 Mar; 50(3):201-206. PubMed ID: 33677882
[No Abstract] [Full Text] [Related]
2. Poorly differentiated chordoma showing loss of SMARCB1/INI1: Clinicopathological and radiological spectrum of nine cases, including uncommon features of a relatively under-recognized entity.
Rekhi B; Michal M; Ergen FB; Roy P; Puls F; Haugland HK; Soylemezoglu F; Kosemehmetoglu K
Ann Diagn Pathol; 2021 Dec; 55():151809. PubMed ID: 34482218
[TBL] [Abstract][Full Text] [Related]
3. Poorly differentiated extra-axial extraskeletal chordoma diagnosed by methylation profiling: case report and analysis of brachyury expression in SWI/SNF-deficient tumors.
Klubíčková N; Michal M; Kinkor Z; Soukup J; Ryška A; Brtková J; Lutonský M; Hájková V; Ptáková N; Michal M; Farkas M; Švajdler M
Virchows Arch; 2024 Apr; 484(4):621-627. PubMed ID: 37594643
[TBL] [Abstract][Full Text] [Related]
4. [Pediatric SMARCB1/INI1-deficient poorly differentiated chordoma of the skull base: report of five cases and review of literature].
Duan ZJ; Yao K; Ma Z; Hu ZJ; Xiang L; Qi XL
Zhonghua Bing Li Xue Za Zhi; 2022 Jan; 51(1):33-38. PubMed ID: 34979751
[No Abstract] [Full Text] [Related]
5. Poorly differentiated chordoma with loss of SMARCB1/INI1 expression in pediatric patients: A report of two cases and review of the literature.
Cha YJ; Hong CK; Kim DS; Lee SK; Park HJ; Kim SH
Neuropathology; 2018 Feb; 38(1):47-53. PubMed ID: 28812319
[TBL] [Abstract][Full Text] [Related]
6. Loss of SMARCB1/INI1 expression in poorly differentiated chordomas.
Mobley BC; McKenney JK; Bangs CD; Callahan K; Yeom KW; Schneppenheim R; Hayden MG; Cherry AM; Gokden M; Edwards MS; Fisher PG; Vogel H
Acta Neuropathol; 2010 Dec; 120(6):745-53. PubMed ID: 21057957
[TBL] [Abstract][Full Text] [Related]
7. Poorly differentiated SMARCB1/INI1-negative chordomas.
Zhao J; Feng J; Chen L; Ma Y; Ding D; Wang H
Clin Neuropathol; 2021; 40(1):36-45. PubMed ID: 32631481
[TBL] [Abstract][Full Text] [Related]
8. Brachyury expression in intracranial SMARCB1-deficient tumors: important points for distinguishing poorly differentiated chordoma from atypical teratoid/rhabdoid tumor.
Kohashi K; Yamamoto H; Yamada Y; Kinoshita I; Oda Y
Hum Pathol; 2021 Jun; 112():1-8. PubMed ID: 33741347
[TBL] [Abstract][Full Text] [Related]
9. [Poorly-differentiated chordoma with INI1 loss: a clinicopathologic study].
Feng JY; Chen L; Ma YY; Yang HW; Chen L
Zhonghua Bing Li Xue Za Zhi; 2017 Oct; 46(10):695-698. PubMed ID: 29050071
[No Abstract] [Full Text] [Related]
10. Clinicopathologic features of four rare types of chordomas, confirmed by brachyury immunostaining.
Rekhi B; Banerjee D; Ramadwar M; Bajpai J; Jambhekar NA
Indian J Pathol Microbiol; 2017; 60(3):350-354. PubMed ID: 28937370
[TBL] [Abstract][Full Text] [Related]
11. [Benign notochordal cell tumor of cervical vertebrae: a clinicopathologic analysis].
Huang J; Jiang Z; Tang J; Zhang H
Zhonghua Bing Li Xue Za Zhi; 2014 Nov; 43(11):763-6. PubMed ID: 25582256
[TBL] [Abstract][Full Text] [Related]
12. Poorly differentiated chordoma: review of 53 cases.
Yeter HG; Kosemehmetoglu K; Soylemezoglu F
APMIS; 2019 Sep; 127(9):607-615. PubMed ID: 31243811
[TBL] [Abstract][Full Text] [Related]
13. Poorly Differentiated Chordomas Showing Loss of INI1/SMARCB1: A Report of 2 Rare Cases With Diagnostic Implications.
Rekhi B; Kosemehmetoglu K; Rane S; Soylemezoglu F; Bulut E
Int J Surg Pathol; 2018 Oct; 26(7):637-643. PubMed ID: 29623728
[TBL] [Abstract][Full Text] [Related]
14. SMARCB1/INI1 Involvement in Pediatric Chordoma: A Mutational and Immunohistochemical Analysis.
Antonelli M; Raso A; Mascelli S; Gessi M; Nozza P; Coli A; Gardiman MP; Arcella A; Massimino M; Buttarelli FR; Giangaspero F
Am J Surg Pathol; 2017 Jan; 41(1):56-61. PubMed ID: 27635948
[TBL] [Abstract][Full Text] [Related]
15. A case of retroperitoneal tumor displaying epithelial differentiation, prominent myxoid stroma and loss of INI1/SMARCB1.
Rekhi B; Thomas A
Pathologica; 2021 Dec; 113(6):456-462. PubMed ID: 34974552
[TBL] [Abstract][Full Text] [Related]
16. Recurrent loss of chromosome 22 and SMARCB1 deletion in extra-axial chordoma: A clinicopathological and molecular analysis.
Wen X; Cimera R; Aryeequaye R; Abhinta M; Athanasian E; Healey J; Fabbri N; Boland P; Zhang Y; Hameed M
Genes Chromosomes Cancer; 2021 Dec; 60(12):796-807. PubMed ID: 34392582
[TBL] [Abstract][Full Text] [Related]
17. SMARCB1/INI1-deficient epithelioid and myxoid neoplasms in paratesticular region: Expanding the clinicopathologic and molecular spectrum.
Yin X; Yang X; Wang S; Zhou J; Zhao M
Ann Diagn Pathol; 2024 Feb; 68():152242. PubMed ID: 38039617
[TBL] [Abstract][Full Text] [Related]
18. Primary adult sellar SMARCB1/INI1-deficient tumor represents a subtype of atypical teratoid/rhabdoid tumor.
Duan Z; Yao K; Yang S; Qu Y; Ren M; Zhang Y; Fan T; Zhao H; Gao J; Feng J; Fan X; Qi X
Mod Pathol; 2022 Dec; 35(12):1910-1920. PubMed ID: 35804041
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary tumor with notochordal differentiation: report of 2 cases suggestive of benign notochordal cell tumor of extraosseous origin.
Kikuchi Y; Yamaguchi T; Kishi H; Azuhata K; Kimizuka G; Hiroshima K; Nakatani Y
Am J Surg Pathol; 2011 Aug; 35(8):1158-64. PubMed ID: 21716081
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of MIB-1, p53, epidermal growth factor receptor, and INI1 in childhood chordomas.
Yadav R; Sharma MC; Malgulwar PB; Pathak P; Sigamani E; Suri V; Sarkar C; Kumar A; Singh M; Sharma BS; Garg A; Bakhshi S; Faruq M
Neuro Oncol; 2014 Mar; 16(3):372-81. PubMed ID: 24305715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
